IMS Partners with NHIA on White Paper Discussing the Impact of Drug & Supply Shortages on the Infusion Industry

IMS was excited to partner with NHIA on this white paper focused on the impact of pandemic-related supply chain issues affecting the home and alternate site infusion industry. We completely understand the challenges of price increases in the industry and will continue to work diligently on behalf of our provider partners. By identifying solutions to help offset these rising costs, our goal is to always support you in providing a high level of care to your patients.
 
The white paper titled Impact of Pandemic-Related Drug and Supply Shortages on the Home and Alternate Site Infusion Industry summarizes the impact of cost increases incurred by infusion providers due to pandemic-related supply shortages, with a particular focus on parenteral nutrition (PN) components and disposable supplies. The white paper offers recommendations for payors regarding ways to ensure complex home infusion services such as PN remain widely available.